Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HOTH | BMY | AMGN | GILD | MRNA |
| Company | Hoth Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1500 | 44.68 | 265.72 | 65.50 | 106.18 |
| High | 1.1900 | 45.37 | 271.68 | 66.35 | 108.15 |
| Low | 1.1200 | 44.34 | 265.72 | 64.63 | 105.25 |
| Last | 1.1600 | 45.28 | 271.08 | 65.75 | 107.64 |
| Change | -0.0100 | +0.58 | +1.70 | +0.48 | +1.46 |
| % Change | -0.85% | +1.30% | +0.63% | +0.74% | +1.38% |
| Volume | 43,079 | 10,895,109 | 920,954 | 8,449,207 | 1,046,805 |
| 20-Day Average Volume | 60,259 | 12,662,701 | 2,079,262 | 6,831,438 | 2,990,779 |
| Previous Close | 1.1700 | 44.70 | 269.38 | 65.27 | 106.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2628 | 49.48 | 270.03 | 68.30 | 105.06 |
| 20-Day Raw Stochastic | 15.67% | 7.76% | 43.97% | 10.94% | 56.48% |
| 20-Day Relative Strength | 42.48% | 30.54% | 46.45% | 30.09% | 54.66% |
| Weighted Alpha | -52.68 | -33.89 | +9.97 | -23.24 | -9.74 |
| Today's Opinion | 100% Sell | 88% Sell | 56% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 88% Sell | 88% Sell | 72% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 8% Sell | 8% Buy | 40% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.88% since 04/19/24 | -7.81% since 04/19/24 | +0.73% since 04/19/24 | -1.78% since 04/19/24 | +6.17% since 04/19/24 |
| Low | 1.1000 on 04/25/24 | 44.34 on 04/26/24 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 99.30 on 04/22/24 |
| High | 1.2300 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | -22.07% since 03/26/24 | -14.16% since 03/26/24 | -3.86% since 03/26/24 | -9.45% since 03/26/24 | +0.24% since 03/26/24 |
| Low | 1.1000 on 04/25/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 97.00 on 04/03/24 |
| High | 1.6000 on 03/27/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -17.06% since 01/26/24 | -9.24% since 01/26/24 | -13.11% since 01/26/24 | -17.54% since 01/26/24 | +5.76% since 01/26/24 |
| Low | 1.1000 on 04/25/24 | 44.34 on 04/26/24 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 84.06 on 02/13/24 |
| High | 1.6700 on 03/19/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | -7.12% since 10/26/23 | -14.84% since 10/26/23 | +0.44% since 10/26/23 | -16.47% since 10/26/23 | +41.71% since 10/26/23 |
| Low | 0.9900 on 11/15/23 | 44.34 on 04/26/24 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 62.55 on 11/02/23 |
| High | 1.7300 on 12/27/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,720 | 90,596,128 | 144,488,960 | 81,266,176 | 40,654,200 |
| Shares Outstanding, K | 4,889 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -7,850,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -1,700,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.63 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.60 on 11/13/23 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 05/20/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 0.00 |